The ability of ∆cJun to reduce LID suggests a possible involvement of dysregulated cJun in dyskinesia. This idea is supported by recent work showing that administration of l-DOPA to mice with a 6-OHDA lesion increases cJun phosphorylation (Spigolon et al. 2018). This evidence concerns the gene JUN and drug-induced dyskinesia.